Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.

MLA

Guo, C. Y., et al. “Long-Term Valproate and Lamotrigine Treatment May Be a Marker for Reduced Growth and Bone Mass in Children with Epilepsy.” Epilepsia, vol. 42, no. 9, Sept. 2001, pp. 1141–47. EBSCOhost, https://doi.org/10.1046/j.1528-1157.2001.416800.x.

APA

Guo, C. Y., Ronen, G. M., & Atkinson, S. A. (2001). Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia, 42(9), 1141–1147. https://doi.org/10.1046/j.1528-1157.2001.416800.x

Chicago

Guo, C Y, G M Ronen, and S A Atkinson. 2001. “Long-Term Valproate and Lamotrigine Treatment May Be a Marker for Reduced Growth and Bone Mass in Children with Epilepsy.” Epilepsia 42 (9): 1141–47. doi:10.1046/j.1528-1157.2001.416800.x.